Skip to content

Matthew Woodruff

I received a BS in biotechnology in 2008 from the Rochester Institute of Technology (RIT). Immediately following, I attended Harvard University as a doctoral candidate in immunology, graduating in 2014 with a thesis describing the earliest phases of immune response following influenza vaccination. In 2014 I pursued a postodoctoral fellowship at Emory University, again studying the early phases of immune response (specifically antibody selection). I published that work in 2018, and transitioned into a human immunology lab under Dr. Iñaki Sanz, specializing in the study of autoimmune diseases. Since the start of the COVID-19 pandemic, I have refocused almost entirely on studying the immune responses in patients with severe COVID-19. I am a member of the Scholars Strategy Network, and have a strong interest in public outreach.

COVID-19 Causes Some Patients’ Immune Systems to Attack Their Own Bodies

Severe infection is linked with autoantibody production.